Nomogram to predict the benefit of additional induction chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Analysis of a multicenter, phase III randomized trial-Reference-Cited by-同舟云学术

Nomogram to predict the benefit of additional induction chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Analysis of a multicenter, phase III randomized trial

Published:2018-10 Issue:1 Volume:129 Page:18-22
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Zhang Yuan,Li Wen-Fei,Liu Xu,Chen Lei,Sun Rui,Sun Ying,Liu Qing,Ma Jun

Funder

Sun Yat-sen University

National Science & Technology Pillar Program

Health & Medical Collaborative Innovation Project of Guangzhou City

Planned Science and Technology Project of Guangdong Province

National Key Research and Development Program of China

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference21 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Re-evaluation of 6th edition of AJCC staging system for nasopharyngeal carcinoma and proposed improvement based on magnetic resonance imaging;Mao;Int J Radiat Oncol Biol Phys,2009

4. Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, Guangdong Province, South China: an age-period-cohort analysis;Zhang;Chin J Cancer,2015

5. Management of nasopharyngeal carcinoma: current practice and future perspective;Lee;J Clin Oncol,2015

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Medicine for Nasopharyngeal Cancer—A Review of Current Prognostic Strategies;Cancers;2024-02-24

2. A Novel Prognostic Model Predicts Outcomes in Non-Metastatic Nasopharyngeal Carcinoma Based on Inflammation, Nutrition, and Coagulation Signature;Journal of Inflammation Research;2023-11

3. Dynamic nomogram for long-term survival in patients with locally advanced oropharyngeal cancer after (chemo)radiotherapy;European Archives of Oto-Rhino-Laryngology;2022-11-24

4. Concurrent chemoradiotherapy combined with nimotuzumab in stage III–IVa nasopharyngeal carcinoma: a retrospective analysis;Journal of Cancer Research and Clinical Oncology;2022-10-27

5. Impact of induction chemotherapy with concurrent chemoradiotherapy on nasopharyngeal carcinoma: A meta-analysis of randomized controlled trials;Frontiers in Oncology;2022-09-13